US Patent 10772942 Lyophilized factor IX formulations
Patent 10772942 was granted and assigned to Bioverativ on September, 2020 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 10772942 Lyophilized factor IX formulations
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
